Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.1.1
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 27025876
Kahle KT, et al. (2016) Inhibition of the kinase WNK1/HSN2 ameliorates neuropathic pain by restoring GABA inhibition. Sci Signal 9, ra32 27025876
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

T906-p - KCC2 iso2 (mouse)
Modsite: SAYTYEKtLVMEQRS SwissProt Entrez-Gene
Orthologous residues
KCC2 (human): T929‑p, KCC2 iso2 (human): T906‑p, KCC2 (mouse): T929‑p, KCC2 iso2 (mouse): T906‑p, KCC2 (rat): T929‑p, KCC2 iso2 (rat): T906‑p
Characterization
Methods used to characterize site in vivo phospho-antibody, western blotting
Relevant cell lines - cell types - tissues:  spinal cord
Cellular systems studied:  tissue
Species studied:  mouse
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
SNI increase
Downstream Regulation
Effect of modification (function):  activity, inhibited

T1008-p - KCC2 iso2 (mouse)
Modsite: PEVHLtWtKDKSVAE SwissProt Entrez-Gene
Orthologous residues
KCC2 (human): T1032‑p, KCC2 iso2 (human): T1009‑p, KCC2 (mouse): T1031‑p, KCC2 iso2 (mouse): T1008‑p, KCC2 (rat): T1032‑p, KCC2 iso2 (rat): T1009‑p
Characterization
Methods used to characterize site in vivo phospho-antibody, western blotting
Relevant cell lines - cell types - tissues:  spinal cord
Cellular systems studied:  tissue
Species studied:  mouse
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
SNI increase
Downstream Regulation
Effect of modification (function):  activity, inhibited

T196-p - NKCC1 (mouse)
Modsite: HQQYYYDtHTNtYYL SwissProt Entrez-Gene
Orthologous residues
NKCC1 (human): T203‑p, NKCC1 iso3 (human): T203‑p, NKCC1 (mouse): T196‑p, NKCC1 (rat): T194‑p
Characterization
Methods used to characterize site in vivo phospho-antibody, western blotting
Relevant cell lines - cell types - tissues:  spinal cord
Cellular systems studied:  tissue
Species studied:  mouse
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
SNI no change compared to control WNK1/HSN2 knockout

T200-p - NKCC1 (mouse)
Modsite: YYDtHTNtYYLRtFG SwissProt Entrez-Gene
Orthologous residues
NKCC1 (human): T207‑p, NKCC1 iso3 (human): T207‑p, NKCC1 (mouse): T200‑p, NKCC1 (rat): T198‑p
Characterization
Methods used to characterize site in vivo phospho-antibody, western blotting
Relevant cell lines - cell types - tissues:  spinal cord
Cellular systems studied:  tissue
Species studied:  mouse
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
SNI no change compared to control WNK1/HSN2 knockout

T205-p - NKCC1 (mouse)
Modsite: TNtYYLRtFGHNtMD SwissProt Entrez-Gene
Orthologous residues
NKCC1 (human): T212‑p, NKCC1 iso3 (human): T212‑p, NKCC1 (mouse): T205‑p, NKCC1 (rat): T203‑p
Characterization
Methods used to characterize site in vivo phospho-antibody, western blotting
Relevant cell lines - cell types - tissues:  spinal cord
Cellular systems studied:  tissue
Species studied:  mouse
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
SNI no change compared to control WNK1/HSN2 knockout

S383-p - STLK3 (mouse)
Modsite: VRRVPGssGHLHKTE SwissProt Entrez-Gene
Orthologous residues
STLK3 (human): S371‑p, STLK3 (mouse): S383‑p, STLK3 (rat): S380‑p
Characterization
Methods used to characterize site in vivo phospho-antibody, western blotting
Relevant cell lines - cell types - tissues:  spinal cord
Cellular systems studied:  tissue
Species studied:  mouse
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
SNI no change compared to control WNK1/HSN2 knockout